Apollo Medical Holdings, Inc. Pronounces Acquisition of Worth-Based mostly Care Expertise Platform Orma Well being, Welcomes New Chief Analytics Officer and President of Supplier Options

ALHAMBRA, Calif., Jan. 27, 2022 /PRNewswire/ — Apollo Medical Holdings, Inc. (“ApolloMed,” and along with its subsidiaries and affiliated entities, the “Firm”) (NASDAQ: AMEH), a number one physician-centric, technology-powered healthcare firm targeted on enabling suppliers within the profitable supply of value-based care, right this moment introduced that it has acquired 100% of the absolutely diluted capitalization of Orma Well being, Inc., and Supplier Development Options LLC (collectively, “Orma Well being”) in accordance with an settlement between ApolloMed, Orma Well being and sure fairness holders of Orma Well being.

ameh logo (PRNewsfoto/Apollo Medical Holdings, Inc.)

ameh brand (PRNewsfoto/Apollo Medical Holdings, Inc.)

ApolloMed acquires value-based care expertise platform Orma Well being.

Based in 2020, Orma Well being has helped many doctor teams transition to and succeed within the supply of value-based care, enabling them to deal with their ardour—caring for sufferers. Orma Well being’s real-time Scientific AI platform ingests information from a number of sources and makes use of superior risk-stratification fashions to establish sufferers for varied medical applications, together with distant affected person monitoring (“RPM”), psychological well being assist, persistent illness administration, and extra. Its medical platform can be deeply built-in with Orma Well being’s proprietary RPM ecosystem, which consists of sensible well being units and a set of expertise instruments to assist handle sufferers’ well being. By means of its suite of AI-driven options, Orma Well being presently serves over 4,000 aligned Medicare beneficiaries in a Direct Contracting Entity (“DCE”) and over 2,500 sufferers in California, Nevada, Arizona and Texas by means of its RPM platform.

Brandon Sim, Co-Chief Govt Officer of ApolloMed, said, “We’re enthusiastic about integrating Orma Well being’s enterprise and technological capabilities with these of ApolloMed, tapping their management group’s expertise in working with DCEs and serving to risk-bearing supplier teams within the supply of value-based care as we increase our capabilities to assist suppliers in varied Facilities for Medicare & Medicaid Providers Innovation Fashions. We consider this acquisition will additional differentiate ApolloMed’s expertise platform and analytic capabilities whereas including complementary strains of enterprise to our operations that function enterprise improvement alternatives.”

By means of leveraging its proprietary expertise platform and in depth value-based care expertise, ApolloMed has traditionally demonstrated super success collaborating in Facilities for Medicare & Medicaid Providers (“CMS”) Innovation Fashions. The acquisition of Orma Well being serves to speed up ApolloMed’s product roadmap in growing an end-to-end expertise platform that allows suppliers to achieve all CMS Innovation Fashions, together with DCE. Orma Well being’s real-time Scientific AI and RPM applied sciences will even be built-in into ApolloMed’s current options for its managed care populations and can additional improve ApolloMed’s expertise and analytics providing to its 1.2 million Medicare Benefit, Managed Medicaid, Business, and ACA members nationwide. This can permit ApolloMed suppliers to obtain a further layer of real-time, actionable insights and proceed delivering high-quality care to their sufferers, tailor-made to their membership populations. As ApolloMed appears to develop its membership and enter new geographies, there are important enterprise improvement alternatives in deepening Orma Well being’s relationships with current RPM suppliers and sufferers and increasing that to ApolloMed’s managed care and CMS Innovation Mannequin options and choices.

As a part of the acquisition, Neil Ahuja, co-founder and Chief Govt Officer of Orma Well being, will be a part of ApolloMed as President, Supplier Options and spearhead continued efforts to allow physicians to transition to value-based care fashions efficiently. Yubin Park, co-founder and Chief Expertise Officer of Orma Well being, will be a part of ApolloMed as Chief Analytics Officer and lead the continued improvement and integration of Orma Well being’s AI-driven supplier enablement expertise into ApolloMed’s expertise platform.

Mr. Ahuja commented, “We’re happy to be becoming a member of ApolloMed, bringing Orma Well being’s core competencies in growing revolutionary healthcare applied sciences that drive tangible outcomes for suppliers and their sufferers. ApolloMed has been a number one healthcare administration firm with a protracted historical past of efficiently and profitably empowering physicians within the supply of value-based care, making it the right companion for us. We look ahead to contributing our experience to increasing ApolloMed’s MSO capabilities and the potential future alternatives that lie forward.”

Mr. Park added, “I’m excited to start working carefully with the ApolloMed group on integrating Orma Well being’s applied sciences with that of ApolloMed. At Orma Well being, we, like ApolloMed, consider that information is king. The data we collect and analyze about our members over time is essential to our capacity to ship the most effective healthcare expertise and outcomes for sufferers. We’re thrilled that Orma Well being is now part of ApolloMed’s worthy mission of empowering suppliers in delivering high-quality care and improved outcomes for its members.”

Based on the phrases of the settlement, a portion of the acquisition value was paid in money to the fairness holders of Orma Well being upon the closing of the transaction, one other portion was paid in ApolloMed inventory to the fairness holders of Orma Well being upon the closing of the transaction, and the rest of the acquisition value is to be paid in a mixture of money and inventory to the fairness holders contingent upon Orma Well being reaching sure operational milestones over the 18 months after the closing. The Firm will fund the transaction from money readily available and shares of ApolloMed inventory.

About Apollo Medical Holdings, Inc.
ApolloMed is a number one physician-centric, technology-powered, risk-bearing healthcare firm. Leveraging its proprietary end-to-end expertise options, ApolloMed operates an built-in healthcare supply platform that allows suppliers to efficiently take part in value-based care preparations, thus empowering them to ship top quality care to sufferers in an economical method.

Headquartered in Alhambra, California, ApolloMed’s subsidiaries and associates embody administration providers organizations (MSOs), affiliated unbiased observe associations (IPAs), and a Subsequent Era Accountable Care Group (NGACO). For extra data, please go to www.apollomed.internet.

Ahead Trying Statements
This press launch accommodates forward-looking statements inside the which means of the Personal Securities Litigation Reform Act of 1995, Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Trade Act of 1934, as amended. Statements included on this press launch that aren’t an outline of historic details are forward-looking statements. Phrases and phrases akin to “consider,” “might,” “may,” “will,” “estimate,” “proceed,” “anticipate,” “intend,” “search,” “plan,” “anticipate,” “ought to,” “would” or related expressions are meant to establish forward-looking statements and are primarily based on the Firm’s present beliefs and expectations. These forward-looking statements embody, with out limitation, statements in regards to the Firm’s acquisition of and preparations with Orma Well being, integration of Orma Well being into ApolloMed operations, advantages and synergies of the transaction, future alternatives for the mixed companies, ApolloMed’s capacity to ship sustainable long-term worth, capacity to answer the altering surroundings, operational focus, strategic progress and enlargement plans, and future collaboration alternatives, and another statements concerning occasions or developments that the Firm believes or anticipates will or might happen sooner or later. Ahead-looking statements mirror present views with respect to future occasions and monetary efficiency and due to this fact can’t be assured. Such statements are primarily based on the present expectations and sure assumptions of ApolloMed’s administration, and a few or all of such expectations and assumptions might not materialize or might differ considerably from precise outcomes. Precise outcomes might also differ materially from forward-looking statements because of dangers, uncertainties and different components, recognized and unknown, together with the danger components described now and again in ApolloMed’s stories filed with the Securities and Trade Fee, together with, with out limitation, the danger components contained in ApolloMed’s Annual Report on Kind 10-Ok for the 12 months ended December 31, 2020, and any subsequent Quarterly Experiences on Kind 10-Q.

Investor Relations
(626) 943-6491

Carolyne Sohn, The Fairness Group
(415) 568-2255



View authentic content material to obtain multimedia:

SOURCE Apollo Medical Holdings, Inc.

Related posts

Is that this weapons expertise the way forward for warfare?


New expertise to future-proof the community


Drone Know-how Market Measurement in Schooling Sector to Develop by USD 499.16 million | 39% of Market Progress to Originate from APAC